The path to tuberculosis elimination: a renewed vision
Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident cases per million population, respectively, were considered achievable for low TB incidence countries in the 1990s, when they were conceived. However, it has since become clear that, even in low TB incidence sett...
Uloženo v:
| Vydáno v: | The European respiratory journal Ročník 61; číslo 6 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
01.06.2023
|
| Témata: | |
| ISSN: | 1399-3003, 1399-3003 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident cases per million population, respectively, were considered achievable for low TB incidence countries in the 1990s, when they were conceived. However, it has since become clear that, even in low TB incidence settings with effective programmes and sufficient resources, achieving pre-elimination in the next decade will require a dramatic acceleration of efforts. In this review, we describe the history of the TB elimination concept and existing country experiences, as well as the interventions available to accelerate the progress towards this threshold. We then propose a framework for near-term progress towards the more aspirational goal of TB pre-elimination. This framework consists of five stages (high incidence, moderate incidence, low incidence, nearing pre-elimination and pre-elimination) that are benchmarked to specific levels of TB incidence in each country. Using this framework, countries can set 5-year targets of achieving certain reductions in TB incidence and/or reaching the next stage, through the use of strategies tailored to both local epidemiology and available organisation and infrastructure. TB elimination remains as an aspirational goal in all stages, but certain activities can be prioritised in the short term to make more rapid progress, ensure local-level buy-in and increase accountability. As TB pre-elimination is approached, certain ethical and social concerns are likely to rise in importance; these concerns are also discussed. Our aim in setting this framework is to guide clinicians, public health experts and decision makers in taking actionable next steps in the trajectory towards TB pre-elimination and elimination. |
|---|---|
| AbstractList | Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident cases per million population, respectively, were considered achievable for low TB incidence countries in the 1990s, when they were conceived. However, it has since become clear that, even in low TB incidence settings with effective programmes and sufficient resources, achieving pre-elimination in the next decade will require a dramatic acceleration of efforts. In this review, we describe the history of the TB elimination concept and existing country experiences, as well as the interventions available to accelerate the progress towards this threshold. We then propose a framework for near-term progress towards the more aspirational goal of TB pre-elimination. This framework consists of five stages (high incidence, moderate incidence, low incidence, nearing pre-elimination and pre-elimination) that are benchmarked to specific levels of TB incidence in each country. Using this framework, countries can set 5-year targets of achieving certain reductions in TB incidence and/or reaching the next stage, through the use of strategies tailored to both local epidemiology and available organisation and infrastructure. TB elimination remains as an aspirational goal in all stages, but certain activities can be prioritised in the short term to make more rapid progress, ensure local-level buy-in and increase accountability. As TB pre-elimination is approached, certain ethical and social concerns are likely to rise in importance; these concerns are also discussed. Our aim in setting this framework is to guide clinicians, public health experts and decision makers in taking actionable next steps in the trajectory towards TB pre-elimination and elimination.Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident cases per million population, respectively, were considered achievable for low TB incidence countries in the 1990s, when they were conceived. However, it has since become clear that, even in low TB incidence settings with effective programmes and sufficient resources, achieving pre-elimination in the next decade will require a dramatic acceleration of efforts. In this review, we describe the history of the TB elimination concept and existing country experiences, as well as the interventions available to accelerate the progress towards this threshold. We then propose a framework for near-term progress towards the more aspirational goal of TB pre-elimination. This framework consists of five stages (high incidence, moderate incidence, low incidence, nearing pre-elimination and pre-elimination) that are benchmarked to specific levels of TB incidence in each country. Using this framework, countries can set 5-year targets of achieving certain reductions in TB incidence and/or reaching the next stage, through the use of strategies tailored to both local epidemiology and available organisation and infrastructure. TB elimination remains as an aspirational goal in all stages, but certain activities can be prioritised in the short term to make more rapid progress, ensure local-level buy-in and increase accountability. As TB pre-elimination is approached, certain ethical and social concerns are likely to rise in importance; these concerns are also discussed. Our aim in setting this framework is to guide clinicians, public health experts and decision makers in taking actionable next steps in the trajectory towards TB pre-elimination and elimination. Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident cases per million population, respectively, were considered achievable for low TB incidence countries in the 1990s, when they were conceived. However, it has since become clear that, even in low TB incidence settings with effective programmes and sufficient resources, achieving pre-elimination in the next decade will require a dramatic acceleration of efforts. In this review, we describe the history of the TB elimination concept and existing country experiences, as well as the interventions available to accelerate the progress towards this threshold. We then propose a framework for near-term progress towards the more aspirational goal of TB pre-elimination. This framework consists of five stages (high incidence, moderate incidence, low incidence, nearing pre-elimination and pre-elimination) that are benchmarked to specific levels of TB incidence in each country. Using this framework, countries can set 5-year targets of achieving certain reductions in TB incidence and/or reaching the next stage, through the use of strategies tailored to both local epidemiology and available organisation and infrastructure. TB elimination remains as an aspirational goal in all stages, but certain activities can be prioritised in the short term to make more rapid progress, ensure local-level buy-in and increase accountability. As TB pre-elimination is approached, certain ethical and social concerns are likely to rise in importance; these concerns are also discussed. Our aim in setting this framework is to guide clinicians, public health experts and decision makers in taking actionable next steps in the trajectory towards TB pre-elimination and elimination. |
| Author | Dowdy, David Denholm, Justin T D'Ambrosio, Lia Centis, Rosella Migliori, Giovanni Battista |
| Author_xml | – sequence: 1 givenname: Giovanni Battista orcidid: 0000-0002-2597-574X surname: Migliori fullname: Migliori, Giovanni Battista email: giovannibattista.migliori@icsmaugeri.it organization: These authors contributed equally to this work – sequence: 2 givenname: David orcidid: 0000-0003-0481-7475 surname: Dowdy fullname: Dowdy, David organization: These authors contributed equally to this work – sequence: 3 givenname: Justin T orcidid: 0000-0002-9214-6431 surname: Denholm fullname: Denholm, Justin T organization: These authors contributed equally to this work – sequence: 4 givenname: Lia orcidid: 0000-0002-7000-5777 surname: D'Ambrosio fullname: D'Ambrosio, Lia organization: Public Health Consulting Group, Lugano, Switzerland – sequence: 5 givenname: Rosella orcidid: 0000-0002-8551-3598 surname: Centis fullname: Centis, Rosella organization: Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37080572$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj0tLw0AUhQep2If-AkFm6Sb1ztxMMnEnpT6g4Kauw9zklo7kZSZR_Pe2WMHVOXx8HDhzMWnahoW4VrBUyuKdwixDAFwCxFkWadB4JmZHGh3x5F-finkI7wAqiVFdiCmmYMGkeiaS7Z5l54a9HFo5jMR9MVZt8EFy5WvfuMG3zb10sueGv7iUnz4cyKU437kq8NUpF-Ltcb1dPUeb16eX1cMmKhDMEBHpHUFsHaDLUiiIyCggZzUZw4YZnS0pKVzsFNkU051JjSJVZFyWVLJeiNvf3a5vP0YOQ177UHBVuYbbMeT6cANQa7QH9eakjlRzmXe9r13_nf991T9sBFh9 |
| CitedBy_id | crossref_primary_10_1080_23744235_2025_2534166 crossref_primary_10_1016_j_ijid_2024_02_023 crossref_primary_10_1084_jem_20241571 crossref_primary_10_1183_13993003_00279_2024 crossref_primary_10_5588_ijtldopen_23_0470 crossref_primary_10_5588_ijtldopen_24_0320 crossref_primary_10_1080_10406638_2023_2261593 crossref_primary_10_1016_S2213_2600_24_00028_6 crossref_primary_10_1183_13993003_01108_2023 crossref_primary_10_1016_j_arbres_2025_03_020 crossref_primary_10_1183_13993003_00638_2025 crossref_primary_10_5588_ijtldopen_23_0342 crossref_primary_10_1007_s11030_024_10946_1 crossref_primary_10_1016_j_cmi_2025_04_020 crossref_primary_10_1183_13993003_02396_2022 crossref_primary_10_5588_ijtldopen_24_0035 crossref_primary_10_5588_ijtldopen_24_0596 crossref_primary_10_3390_tropicalmed9020029 crossref_primary_10_2807_1560_7917_ES_2025_30_11_2500172 crossref_primary_10_1186_s12879_025_11449_6 crossref_primary_10_1183_13993003_00104_2024 crossref_primary_10_1183_13993003_02215_2023 crossref_primary_10_1016_j_arbres_2023_09_002 crossref_primary_10_3390_diagnostics14131334 crossref_primary_10_1016_j_cmi_2024_06_003 crossref_primary_10_1016_j_ijid_2024_106988 crossref_primary_10_1183_13993003_02000_2024 crossref_primary_10_5588_ijtldopen_25_0050 crossref_primary_10_1016_j_cmi_2025_02_028 |
| ContentType | Journal Article |
| Copyright | Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org. |
| Copyright_xml | – notice: Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1183/13993003.00499-2023 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1399-3003 |
| ExternalDocumentID | 37080572 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- .55 .GJ 18M 1OC 2WC 31~ 3O- 53G 5GY 5RE 5VS 8-1 AADJU AAFWJ AAZMJ ABCQX ABJNI ABOCM ABSQV ACEMG ACGFO ACPRK ACXQS ADBBV ADDZX ADMOG AENEX AFFNX AFHIN AFZJQ AIZTS AJAOE ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CAG CGR COF CS3 CUY CVF DIK E3Z EBS ECM EIF EJD F5P F9R GX1 H13 INIJC J5H KQ8 L7B LH4 LW6 NPM OK1 P2P PQQKQ R0Z RHF RHI TER TR2 W8F WOQ X7M ZE2 ZGI ZXP ~02 7X8 ADYFA |
| ID | FETCH-LOGICAL-c305t-bb2fb048a03a970cbbb510ba82b55e5ee3a8db6ca4a1b8737f5751b1c9eddbde2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 41 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001021063000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1399-3003 |
| IngestDate | Fri Sep 05 12:15:31 EDT 2025 Wed Feb 19 02:07:55 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c305t-bb2fb048a03a970cbbb510ba82b55e5ee3a8db6ca4a1b8737f5751b1c9eddbde2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-9214-6431 0000-0002-2597-574X 0000-0003-0481-7475 0000-0002-7000-5777 0000-0002-8551-3598 |
| PMID | 37080572 |
| PQID | 2805032238 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2805032238 pubmed_primary_37080572 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-01 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The European respiratory journal |
| PublicationTitleAlternate | Eur Respir J |
| PublicationYear | 2023 |
| References | 37419520 - Eur Respir J. 2023 Jul 7;61(6) 38575168 - Eur Respir J. 2024 Apr 4;63(4) |
| References_xml | – reference: 38575168 - Eur Respir J. 2024 Apr 4;63(4): – reference: 37419520 - Eur Respir J. 2023 Jul 7;61(6): |
| SSID | ssj0016431 |
| Score | 2.5784144 |
| SecondaryResourceType | review_article |
| Snippet | Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident cases per million population, respectively, were considered achievable... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| SubjectTerms | Antitubercular Agents - therapeutic use Humans Incidence Public Health Tuberculosis - drug therapy Tuberculosis - epidemiology Tuberculosis - prevention & control |
| Title | The path to tuberculosis elimination: a renewed vision |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37080572 https://www.proquest.com/docview/2805032238 |
| Volume | 61 |
| WOSCitedRecordID | wos001021063000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPAat23aTepFRFy87LIHhb2VTDKFBdmu267-fTNtlz0JgpccAoEyM19mki-dj7G7XCrnQQYCw1yKOJXOYy6VIgSfXlHHVgHUYhNqNNKTSTpuL9zK9lnlak-sN2pXWLoj70WaOpf4ZKYf55-CVKOIXW0lNDZZR_pShqJaTdYsgs-2zYErJX4_kG3XIR_FPZqjqfu65hckIv57jVnnmsH-f7_ygO21VSZ_asLikG3g7IjtDFse_Zj1fXRwEiPmVcGrJeDCLj-Kclpy_KhlvshdD9xwanj5jY43v6CfsPfBy9vzq2gVFIT1OK4EQJSDx6gJpElVYAHAYxCMjiBJMEGURjvoWxObELSSKicaBkKbonPgMDplW7NihueMh5ZOP2AjpazP6lZr0BBiDBBgP5Fxl92uLJL5CCXawcywWJbZ2iZddtaYNZs3rTQyqXzFmqjo4g-rL9kuual5p3XFOrnHJ16zbftVTcvFTe16P47Gwx-mmrcv |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+path+to+tuberculosis+elimination%3A+a+renewed+vision&rft.jtitle=The+European+respiratory+journal&rft.au=Migliori%2C+Giovanni+Battista&rft.au=Dowdy%2C+David&rft.au=Denholm%2C+Justin+T&rft.au=D%27Ambrosio%2C+Lia&rft.date=2023-06-01&rft.issn=1399-3003&rft.eissn=1399-3003&rft.volume=61&rft.issue=6&rft_id=info:doi/10.1183%2F13993003.00499-2023&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1399-3003&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1399-3003&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1399-3003&client=summon |